Next Article in Journal
The Importance of a Participatory and Integrated One Health Approach for Rabies Control: The Case of N’Djaména, Chad
Next Article in Special Issue
Biosocial Determinants of Persistent Schistosomiasis among Schoolchildren in Tanzania despite Repeated Treatment
Previous Article in Journal
Evaluation of Bait Station Density for Oral Rabies Vaccination of Raccoons in Urban and Rural Habitats in Florida
Previous Article in Special Issue
Polisye Kont Moustik: A Culturally Competent Approach to Larval Source Reduction in the Context of Lymphatic Filariasis and Malaria Elimination in Haiti
Article Menu

Export Article

Open AccessReview

The Interdependence between Schistosome Transmission and Protective Immunity

Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2017, 2(3), 42;
Received: 17 July 2017 / Revised: 2 August 2017 / Accepted: 8 August 2017 / Published: 23 August 2017
PDF [515 KB, uploaded 23 August 2017]


Mass drug administration (MDA) for control of schistosomiasis is likely to affect transmission dynamics through a combination of passive vaccination and reduction of local transmission intensity. This is indicated in phenomenological models of immunity and the impact of MDA, yet immunity parameters in these models are not validated by empirical data that reflects protective immunity to reinfection. There is significant empirical evidence supporting the role of IgE in acquired protective immunity. This is proposed to be a form of delayed concomitant immunity, driven at least in part by protective IgE responses to the tegument allergen-like (TAL) family of proteins. Specific questions have arisen from modeling studies regarding the strength and duration of the protective immune response. At present, field studies have not been specifically designed to address these questions. There is therefore a need for field studies that are explicitly designed to capture epidemiological effects of acquired immunity to elucidate these immunological interactions. In doing so, it is important to address the discourse between theoretical modelers and immuno-epidemiologists and develop mechanistic models that empirically define immunity parameters. This is of increasing significance in a climate of potential changing transmission dynamics following long-term implementation of MDA. View Full-Text
Keywords: schistosomes; IgE; immunity; transmission dynamics schistosomes; IgE; immunity; transmission dynamics

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Oettle, R.C.; Wilson, S. The Interdependence between Schistosome Transmission and Protective Immunity. Trop. Med. Infect. Dis. 2017, 2, 42.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Trop. Med. Infect. Dis. EISSN 2414-6366 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top